These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9616733)
1. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Geller RL; Loudovaris T; Neuenfeldt S; Johnson RC; Brauker JH Ann N Y Acad Sci; 1997 Dec; 831():438-51. PubMed ID: 9616733 [No Abstract] [Full Text] [Related]
3. Purification of polymers used for fabrication of an immunoisolation barrier. Prokop A; Wang TG Ann N Y Acad Sci; 1997 Dec; 831():223-31. PubMed ID: 9616714 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells as adjuvants for immune-mediated resistance to tumors. Schuler G; Steinman RM J Exp Med; 1997 Oct; 186(8):1183-7. PubMed ID: 9379142 [No Abstract] [Full Text] [Related]
8. Adoptive immunotherapy using autologous lymphocytes sensitized with HLA class I-matched allogeneic tumor cells. Yamaguchi Y; Ohshita A; Hironaka K; Okita R; Okawaki M; Matsuura K; Nagamine I; Ikeda T; Ohara M; Hihara J Oncol Rep; 2006 Jul; 16(1):165-9. PubMed ID: 16786141 [TBL] [Abstract][Full Text] [Related]
9. The promise of T-lymphocyte immunotherapy for the treatment of malignant disease. Thomas AK; June CH Cancer J; 2001; 7 Suppl 2():S67-75. PubMed ID: 11777267 [TBL] [Abstract][Full Text] [Related]
10. [REDUCTION OF THE PLASMA CONCENTRATION OF THE CHARLOTTE FRIEND LEUKEMOGENIC VIRUS BY ADOPTIVE IMMUNOTHERAPY (GRAFT OF ALLOGENIC BONE MARROW)]. MATHE G; AMIEL JL C R Hebd Seances Acad Sci; 1964 Dec; 259():4408-10. PubMed ID: 14256003 [No Abstract] [Full Text] [Related]
12. Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer. Marcus A; Eshhar Z Oncotarget; 2011 Jul; 2(7):525-6. PubMed ID: 21719916 [No Abstract] [Full Text] [Related]
13. Natural killer cell therapy for cancer: delivering on a promise. Shook DR; Leung W Transfusion; 2013 Feb; 53(2):245-8. PubMed ID: 23384099 [No Abstract] [Full Text] [Related]
14. Editorial to Theme Issue on Cell Based Therapeutics. Hoogendoorn KH; Bravery CA Pharm Res; 2019 Jan; 36(3):41. PubMed ID: 30673889 [No Abstract] [Full Text] [Related]
15. Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation. Cieri N; Mastaglio S; Oliveira G; Casucci M; Bondanza A; Bonini C Immunol Rev; 2014 Jan; 257(1):165-80. PubMed ID: 24329796 [TBL] [Abstract][Full Text] [Related]
17. Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials. Suen WC; Lee WY; Leung KT; Pan XH; Li G Cancer Invest; 2018; 36(8):431-457. PubMed ID: 30325244 [TBL] [Abstract][Full Text] [Related]
18. Microencapsulation of cells. Medical applications. Sun AM Ann N Y Acad Sci; 1997 Dec; 831():271-9. PubMed ID: 9616719 [No Abstract] [Full Text] [Related]
19. [Immunization by xenogeneic transplantation of tumor cells: experimental and prospective studies in clinical immunotherapy]. Sega E Boll Ist Sieroter Milan; 1971; 50(3):231-6. PubMed ID: 5146578 [No Abstract] [Full Text] [Related]
20. [Immunological phenomena and carcinogenesis]. Srebro Z Postepy Hig Med Dosw; 1971; 25(3):391-414. PubMed ID: 5571144 [No Abstract] [Full Text] [Related] [Next] [New Search]